Ukuthelekisa isitofu sokugonya sikaJohnson & Johnson neModerna, iPfizer's Now That Is Approved

Ukugunyazisa ukusetyenziswa ngokungxamisekileyo kukaJohnson & Johnson Isitofu se-covid-19 ikufutshane nekona. NgoLwesihlanu, i-FDA's Vaccines kunye neKomiti yeeNgcebiso zeMveliso yezebhayoloji ehambelanayo ivumile isitofu sokugonya emva kwentlanganiso yosuku lonke yokuvavanya ukhuseleko nokusebenza kwedatha. I-FDA ihlala ikhupha isigunyaziso esisemthethweni kwisithuba seeyure ezingama-24 zokuvunywa kwekomiti, oko kuthetha ukuba isitofu sokugonya i-J & J singaqala ukuhambisa kwangoko nje ngoMgqibelo.

Iingcali zempilo yoluntu zinethemba elikhulu lokugonya i-J & J ukunceda ekunciphiseni ukubonelelwa nge-vaccine e-US ngenxa yesakhiwo sayo sokudubula kunye neemfuno ezingqongqo zokugcina kunalezo zenziwe nguModerna kunye I-Pfizer / BioNTech.

I-J & J iceba ukuthumela i-20 yezigidi eMelika ukuphela kuka-Matshi kunye nezinye iidosi ezingama-80 ezizigidi ngaphambi kokuphela kukaJuni. Idityaniswe ne-300 yezigidi zeedosi ezathenjiswa nguModerna kunye ne-200 yeedosi ngePfizer, kuya kubakho okungaphezulu kunako ukonela bonke abantu base-US ngehlobo.

Ngelixa ukwakheka kwethamo elinye le-J & J kunesibheno esomeleleyo, abanye abantu baye babuza ukuba kufuneka basifumane ngenxa yezinga eliphantsi lokusebenza kwalo. Idatha yolingo lwe-J & J lubonisa ukuba isitofu sisebenza kuphela ngeepesenti ezingama-66 kuthintelo losuleleko lweempawu ze-COVID-19. Umgangatho wokusebenza kwawo e-US uphakame kancinci kwiipesenti ezingama-72, usasalele ngasemva kwinqanaba lama-95 leepesenti elifezekiswe nguModerna kunye nePfizer. Okwangoku, kubantu abasesichengeni, kuphezulu kakhulu kunokungabikho gonyo kwaphela.

Nalu uluhlu lweemitha eziphambili zokugonya kwe-J & J xa kuthelekiswa nePfizer neModerna:

Ubungakanani

I-J & J: Ithamo elinye.

Moderna: Amanani amabini, anikwe ngenyanga ngaphandle.

I-Pfizer / BioNTech: Amanani amabini, anikwe iiveki ezintathu ngaphandle.

Inqanaba lokuSebenza

I-J & J: Iipesenti ezingama-72 ziyasebenza ekuthinteleni isifo se-COVID-19 yosulelo e-US; I-85% iyasebenza kwiimeko ezinzima.

I-Moderna: Iipesenti ezingama-94.1 kwiimeko ezinempawu emva kwethamo lesibini; ukusebenza okuncinci kancinci kubantu abangama-65 nangaphezulu.

I-Pfizer / BioNTech: Iipesenti ezingama-95 ngokuchasene neemeko zeempawu emva kwethamo lesibini.

Inani ekujoliswe kulo

I-J & J: Abantu abaneminyaka eli-18 nangaphezulu.

IModerna: Abantu abaneminyaka eli-18 nangaphezulu.

I-Pfizer / BioNTech: Abantu abaneminyaka eli-16 nangaphezulu.

Imiphumela

I-J & J: Intloko ebuhlungu, ukudinwa kunye neentlungu zezihlunu zezona zinto zichaphazeleka kakhulu, ngokwe- Ingxelo ye-FDA Ikhutshwe ngoLwesithathu.

IModerna: Ukugodola, umkhuhlane, intloko ebuhlungu, ukuphefumla kancinci kunye nentlungu engalweni, ngokutsho idatha yesilingo kunye nabanye abathathi-nxaxheba babelana ngamava kwimidiya yoluntu.

I-Pfizer / BioNTech: Ukugodola, umkhuhlane, ukudinwa, ukuba bomvu kunye nokudumba, ngokweenkcukacha zetyala.

Ixabiso (idosi nganye)

Zontathu ezi zitofu ziya kunikwa uluntu simahla (ubuncinci okwangoku). Kodwa amaxabiso apho bathengiswa khona kurhulumente wobumbano phantsi kwenkqubo yeWebhu yokuSebenza yeWarp iyahluka. Ixabiso lokugonya ayisiyiyo inkxalabo enkulu kubathengi. Nangona kunjalo, inokuba yinto ephantsi kwendlela xa iinkqubo zikarhulumente ziphuma kwaye ukuba ziyafuneka kwakhona izithonga.

I-J & J: $ 10

Namhlanje: $ 15

I-Pfizer / BioNTech: $ 20

Ukubonelela

I-J & J: i-100 yezigidi zeedosi ezi-odolwe ukuba zithunyelwe ukuphela kukaJuni; Izigidi ezingama-20 zithenjiswe ukuphela kuka-Matshi.

IModerna: iidosi ezizigidi ezingama-300 ziyalelwe; I-100 lezigidi ithenjisiwe ukuphela kuka-Matshi; Izigidi ezingama-41 esele zilawulwe e-U.S.

I-Pfizer / BioNTech: i-200 yezigidi zeedosi ezi-odolwe ukuba zithunyelwe ukuphela kukaJulayi; Izigidi ezili-100 zathembiswa ukuphela kuka-Matshi.